Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Jiatong Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200…. Hauptthemen laut MEDLINE: Alkenes, Antineoplastic Agents, Cell Proliferation, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Pancreatobililary cancers are fatal solid tumors that pose a significant threat to human life. It is imperative to investigate novel small molecule active compounds for controlling these cancers. Heterocyclic compounds (e. g. gemcitabine) and multi‐substituted alkenes (e. g. resveratrol) are commonly applied in tumor treatment. Researchers have proposed that the synthesis of new trisubstituted alkenes containing heteroaromatic rings by combining these two scaffolds may be a fresh strategy to develop new active molecules. In this study, we utilized alkenyl bromide and heteroaryl boronic acid as substrates, employing Suzuki coupling to generate a series of triarylethylenes featuring nitrogen, oxygen, and sulfur atoms. Through in vitro experiments, the results indicated that some compounds exhibited remarkable anti‐tumor efficacy (e. g. IC50 [ 3be , GBC‐SD] =0.13 μM and IC50 [ 3be , PANC‐1] =0.27 μM). The results further demonstrated that the antitumor efficacy of these compounds was dependent on the heteroatom, π‐system, skeleton‐bonding site, and substituent type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200032, Shanghai, China.
- Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200127, Shanghai, China.
ORCID-Profile: Jiatong Li, Meng-Yao Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Gu, A., & Li, M. Y. (2024). Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401469
Vancouver
Li J, Gu A, Li MY. Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401469
BibTeX
@article{Li2024,
author = {Li, Jiatong and Gu, Ao and Li, Meng-Yao},
title = {Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401469}
}
EUVIMED